Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
NA
INTERVENTIONAL
2022-04-01
2022-04-02
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Interventions in Mathematics and Cognitive Skills
NCT05201534
Effects of Social Gaze Training on Brain and Behavior in Fragile X Syndrome
NCT02616796
Task-Oriented Writing Intervention for Preschoolers
NCT07332559
Intensive Intervention for Toddlers With Autism (EARLY STEPS)
NCT00698997
Social Cognition and Turner Syndrome
NCT01687842
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
ANS training
ANS training
In-home computer-based ANS training
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
ANS training
In-home computer-based ANS training
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Healthy controls.
* Normal or corrected to normal vision.
Exclusion Criteria
* Chemical dependency
* Currently taking the following medications: antidepressant, antipsychotic, and anti-seizures drugs.
6 Years
40 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Stanford University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Joseph Michael Baker
Instructor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Center for Interdisciplinary Brain Sciences Research
Stanford, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
092883
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.